Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...

Descripción completa

Detalles Bibliográficos
Autores principales: Sophie, Raafay, Akhtar, Abeer, Sepah, Yasir J., Ibrahim, Mohamed, Bittencourt, Millena, Do, Diana V., Nguyen, Quan Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://www.ncbi.nlm.nih.gov/pubmed/24392297
http://dx.doi.org/10.1007/s13554-012-0003-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://www.ncbi.nlm.nih.gov/pubmed/24392297
http://dx.doi.org/10.1007/s13554-012-0003-4

Ejemplares similares